A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer

被引:0
|
作者
Takuro Kainuma
Shogo Kawakami
Hideyasu Tsumura
Takefumi Satoh
Ken-ichi Tabata
Masatsugu Iwamura
Kazushige Hayakawa
Hiromichi Ishiyama
机构
[1] Kitasato University School of Medicine,Department of Radiation Oncology
[2] Kitasato University School of Medicine,Department of Urology
来源
关键词
Prostate cancer; Stereotactic body radiotherapy; Dose-escalation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors
    Le, Quynh-Thu
    Loo, Billy W.
    Ho, Anthony
    Cotrutz, Christian
    Koong, Albert C.
    Wakelee, Heather
    Kee, Stephen T.
    Constantinescu, Dana
    Whyte, Richard I.
    Donington, Jessica
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) : 802 - 809
  • [32] Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
    Kim, Jun Won
    Seong, Jinsil
    Lee, Ik Jae
    Woo, Joong Yeol
    Han, Kwang-Hyub
    ONCOTARGET, 2016, 7 (26) : 40756 - 40766
  • [33] 5-Year Outcomes of a Phase 1 Dose Escalation Study Using Stereotactic Body Radiosurgery for Patients with Clinically Localized Prostate Cancer
    Zelefsky, M. J.
    Kollmeier, M. A.
    McBride, S.
    Pei, X.
    Happersett, L.
    Lin, M.
    Cox, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S156 - S157
  • [34] DOSE ESCALATION AND QUALITY OF LIFE IN PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH RADIOTHERAPY: LONG-TERM RESULTS OF THE DUTCH RANDOMIZED DOSE-ESCALATION TRIAL (CKTO 96-10 TRIAL)
    Al-Mamgani, Abrahim
    van Putten, Wim L. J.
    van der Wielen, Gerard J.
    Levendag, Peter C.
    Incrocci, Luca
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1004 - 1012
  • [35] The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments
    Mesci, Aruz
    Isfahanian, Naghmeh
    Dayes, Ian
    Lukka, Himu
    Tsakiridis, Theodoros
    CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : E25 - E38
  • [36] A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
    Wolfe, Sydney
    Diven, Marshall A.
    Marciscano, Ariel E.
    Zhou, Xi Kathy
    Kishan, A. U.
    Steinberg, M. L.
    Miccio, Joseph A.
    Camilleri, Philip
    Nagar, Himanshu
    BMC CANCER, 2023, 23 (01)
  • [37] A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
    Sydney Wolfe
    Marshall A. Diven
    Ariel E. Marciscano
    Xi Kathy Zhou
    A. U. Kishan
    M. L. Steinberg
    Joseph A. Miccio
    Philip Camilleri
    Himanshu Nagar
    BMC Cancer, 23
  • [38] Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study
    Alayed, Yasir
    Loblaw, Andrew
    Chu, William
    Al-Hanaqta, Motasem
    Chiang, Andrew
    Jain, Suneil
    Chung, Hans
    Vesprini, Danny
    Morton, Gerard
    Ravi, Ananth
    Davidson, Melanie
    Deabreu, Andrea
    Mamedov, Alexandre
    Zhang, Liying
    Erler, Darby
    Cheung, Patrick
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1066 - 1073
  • [39] Daily-diary evaluated side effects of dose-escalation radiotherapy of prostate cancer using the stereotactic Beamcath® technique
    Fransson, P
    Bergström, P
    Löfroth, PO
    Franzén, L
    Henriksson, R
    Widmark, A
    ACTA ONCOLOGICA, 2003, 42 (04) : 326 - 333
  • [40] STEREOTACTIC BODY RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: INTERIM RESULTS OF A PROSPECTIVE PHASE II CLINICAL TRIAL
    King, Christopher R.
    Brooks, James D.
    Gill, Harcharan
    Pawlicki, Todd
    Cotrutz, Cristian
    Presti, Joseph C., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1043 - 1048